Core A: Administrative Core

核心A:行政核心

基本信息

项目摘要

ABSTRACT: ADMINISTRATIVE CORE The Administrative Core oversees operational and strategic planning for the University of Kansas Alzheimer's Disease Research Center (KU ADRC). Over a decade of P30 support, the Core managed growth that saw us become a leader in AD mitochondria/metabolism, lifestyle intervention, and prevention research. Supporting these programs required us to develop and implement unique infrastructure that promotes specialized molecular, clinical trial, recruitment, education, and patient care initiatives. In addition to defining Center strategy, the Core manages the resources needed to support our investigators. This includes biospecimen procurement plans; consent and compliance requirements; ensuring biospecimen storage; and facilitating access to biospecimens, data, consultation, and other Center services. We advise our other cores, monitor their productivity, and promote their seamless and synergistic cooperation. We verify NIA programmatic obligations are efficiently met and maintain Internal and External Advisory Committees. Up to this point we ran an immensely successful pilot project program; from 2011 through 2019 we saw 27 of 40 (68%) of our pilot recipients receive external grant support. The Core ensures all KU ADRC components receive adequate financial resources. Beyond managing our P30 budget, we accomplish this by identifying and procuring dollars from institutional ADRC stakeholders, developing philanthropy, and submitting P30 supplements. Whether designing strategy, tracking down dollars, identifying space, building resources, developing investigators, or growing the Center and advancing its agenda, the Administrative Core plays an integral role in both short-and-long term KU ADRC successes. Over the past 10 years we clearly transformed AD, AD-related, and brain aging research at the University of Kansas. During our next cycle we will continue our trajectory of guided, strategic growth that advances the AD research field and moves us closer to effective treatments and prevention strategies. We will accomplish these goals by focusing on a defined set of specific aims that include: (1) Managing infrastructure and routine operations; (2) Developing and empowering intellectual assets; and (3) Defining goals and amplifying impact.
摘要:行政核心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUSSELL H. SWERDLOW其他文献

RUSSELL H. SWERDLOW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUSSELL H. SWERDLOW', 18)}}的其他基金

University of Kansas Alzheimers Disease Center P30 Neuropathology supplement
堪萨斯大学阿尔茨海默病中心 P30 神经病理学补充
  • 批准号:
    10741516
  • 财政年份:
    2021
  • 资助金额:
    $ 50.57万
  • 项目类别:
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
堪萨斯大学阿尔茨海默病研究中心 (KU ADRC)
  • 批准号:
    10466947
  • 财政年份:
    2021
  • 资助金额:
    $ 50.57万
  • 项目类别:
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
堪萨斯大学阿尔茨海默病研究中心 (KU ADRC)
  • 批准号:
    10666543
  • 财政年份:
    2021
  • 资助金额:
    $ 50.57万
  • 项目类别:
Core F: Biomarker Core
核心 F:生物标志物核心
  • 批准号:
    10264628
  • 财政年份:
    2021
  • 资助金额:
    $ 50.57万
  • 项目类别:
University of Kansas Alzheimers Disease
堪萨斯大学阿尔茨海默病
  • 批准号:
    10655210
  • 财政年份:
    2021
  • 资助金额:
    $ 50.57万
  • 项目类别:
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
堪萨斯大学阿尔茨海默病研究中心 (KU ADRC)
  • 批准号:
    10264622
  • 财政年份:
    2021
  • 资助金额:
    $ 50.57万
  • 项目类别:
Mechanistic Basis of the mtDNA Haplogroup J-Alzheimer's Disease Association
mtDNA 单倍群 J-阿尔茨海默病协会的机制基础
  • 批准号:
    10565875
  • 财政年份:
    2019
  • 资助金额:
    $ 50.57万
  • 项目类别:
Mechanistic Basis of the mtDNA Haplogroup J-Alzheimer's Disease Association
mtDNA 单倍群 J-阿尔茨海默病协会的机制基础
  • 批准号:
    10353367
  • 财政年份:
    2019
  • 资助金额:
    $ 50.57万
  • 项目类别:
Oxaloacetate's Brain Effects
草酰乙酸对大脑的影响
  • 批准号:
    8418687
  • 财政年份:
    2012
  • 资助金额:
    $ 50.57万
  • 项目类别:
Oxaloacetate's Brain Effects
草酰乙酸对大脑的影响
  • 批准号:
    8256105
  • 财政年份:
    2012
  • 资助金额:
    $ 50.57万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 50.57万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 50.57万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 50.57万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 50.57万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 50.57万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 50.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了